Transvription in eukaryotes and prokaryote, trasulation in both
transcription prokaryote eukaryote RNA polymerase promoter

This figure presents single-molecule fluorescence resonance energy transfer (smFRET) data analyzing bacterial RNA polymerase transcription kinetics. Panels A, B, C, and E show representative time traces of FRET efficiency (E*) as a function of time (seconds), monitoring DNA scrunching during initial transcription. A baseline state (E* ~0.22) represents the open promoter complex (RPo). In Trace A (85% of cases), E* increases to a stable scrunched state (~0.37). Traces B and C (10%) demonstrate pausing at E* ~0.37 (blue shaded area) before a transient excursion to a higher FRET state (~0.45, yellow shaded area), assigned to a 7-nt RNA complex. Trace B shows 'backtracking' to the 0.37 state, while Trace C shows 'RNA release' back to the RPo baseline. Trace E (5%) shows a direct transition to the 0.45 state. Panel D contains two dwell-time histograms with single-exponential fits. The left histogram quantifies the paused state duration (τpause = 24 ± 2 s), and the right histogram quantifies the excursion state duration (τexcurs = 5.1 ± 0.3 s). The data illustrates the biophysical mechanism of transcriptional pausing and backtracking regulated by the σ3.2 finger during RNA synthesis.

This figure presents single-molecule fluorescence resonance energy transfer (smFRET) time trajectories of RNA polymerase (RNAP) clamp dynamics during promoter binding and unwinding. The data is categorized into four classes based on the E* (apparent FRET efficiency) trajectories, which serve as a proxy for clamp conformational states. Class I (45%) shows a stable closed-clamp state (E* ≈ 0.40, highlighted in orange). Class II (44%) demonstrates a transition from a closed-clamp state to a higher E* 'locked-clamp' state (E* ≈ 0.48, highlighted in red). Class III (9%) begins in a locked-clamp state and reverts to a closed-clamp state. Class IV (2%) is rare, showing fluctuations between closed and 'open-clamp' states (E* ≈ 0.20, highlighted in cyan). The trajectories were analyzed using a Hidden Markov Model (HMM), with colored bands representing distinct structural states. This visualization illustrates the 'bind-unwind-load-and-lock' mechanism of bacterial transcription initiation, emphasizing that the RNAP clamp remains closed or locked throughout the promoter unwinding process.

This scientific visualization presents fluorescence intensity records from single-molecule CoSMoS (Colocalization Single-Molecule Spectroscopy) experiments, used to study transcription initiation mechanisms at the rRNA promoter rrnB P1. The image contains six separate panels, each plotting fluorescence in Arbitrary Units (AU) over time in seconds (s). Within each panel, three distinct signal traces are vertically stacked: 1. Top (Grey): AF488-oligo probe signal, indicating transcript hybridization. 2. Middle (Red): σ70RNAP647 signal, indicating RNA polymerase holoenzyme presence at the DNA template. 3. Bottom (Green): GreBCy3B signal, indicating the presence of the transcript cleavage factor GreB. Two types of molecular interactions are highlighted with colored vertical bars: - Pink bars indicate transcription initiation events, characterized by a persistent increase in the red σ70RNAP647 trace followed by a spike in the top grey AF488 probe trace (successful transcription). - Orange bars indicate co-localization events where σ70RNAP647 and GreBCy3B arrive and depart simultaneously from the DNA, representing the formation of a polymerase-GreB complex that fails to initiate transcription (inhibitory interaction). These records demonstrate how GreB binding to the RNAP holoenzyme before DNA association introduces a barrier to initiation, effectively repressing rRNA synthesis.

A detailed molecular pathophysiology diagram illustrating the Transcription-Coupled Nucleotide Excision Repair (TC-NER) pathway in human cells. The seven-step flowchart depicts the cellular response to DNA damage during transcription. (1) Initiation: RNA Polymerase II (RNAPII), TFIIH, and XPC assemble at the promoter. (2) Elongation and Stall: RNAPII and CSB encounter a DNA lesion (yellow starburst). (3) Signaling: Stalled polymerase triggers p53-dependent or independent apoptosis, contributing to aging and tissue degeneration. (4) Preparation for Repair: RNAPII undergoes polyubiquitylation (Ub) involving UVSSA and p97, leading to its degradation by the proteasome to clear the site. (5) Excision: TFIIH unwinds the DNA helix while RPA coats single-stranded segments. Endonucleases XPG and XPF-ERCC1 perform dual incisions to remove the damaged oligonucleotide. (6) Resynthesis: DNA polymerases delta/epsilon (Pol δ,ε), aided by PCNA and RFC, fill the gap, and DNA ligase seals the remaining nick. (7) Restoration: Re-initiation of transcription following successful repair. This diagram serves as an educational tool for genetics and molecular oncology, focusing on DNA maintenance mechanisms.
translation ribosome tRNA aminoacyl peptidyl elongation steps

Educational pathophysiology diagram illustrating the mechanisms of action for four classes of protein synthesis inhibitors acting on the bacterial ribosome. The diagram is divided into four numbered quadrants: (1) Tetracyclines, represented by red linked circles, are shown binding to the 30S small subunit, which physically blocks aminoacyl-tRNA from binding to the A-site, thereby inhibiting translation. (2) Aminoglycosides, depicted as green bars, demonstrate three distinct mechanisms: (A) blocking the initiation of protein synthesis, (B) inhibiting tRNA translocation from the A-site to the P-site, and (C) causing mRNA misreading, leading to the incorporation of incorrect amino acids. (3) Macrolides, Lincosamides, and Type B Streptogramins are shown blocking the polypeptide exit tunnel of the 50S large subunit, preventing the extension of the growing peptide chain. (4) Oxazolidinones, shown as purple circles, bind to the 50S subunit at the peptidyl transferase center, inhibiting the formation of the 70S initiation complex and blocking early translation steps. Each panel illustrates key components including the 50S and 30S subunits, mRNA, tRNA, and the growing peptide chain.

This pathophysiology diagram illustrates the impact of oxidative stress (H2O2) on the translational elongation rate in Escherichia coli, highlighting the role of tRNA pools. The schematic is divided into three tiers: 1) Normal condition: High tRNA pools facilitate fast ribosome elongation rates on mRNA. 2) Low to moderate H2O2 (0.1-5 mM): Oxidized OxyR transcription factor activates stress-defense genes (katG, ahpCF, trxC). However, low tRNA availability causes slow elongation, leading to a lag time before stress-defense proteins accumulate to neutralize H2O2, eventually allowing growth recovery. 3) High H2O2 (>6 mM): Despite OxyR activation, an extreme tRNA shortage leads to translation arrest. Ribosomes (depicted in gray) fail to synthesize stress-defense proteins, resulting in no growth recovery and cell death. The diagram teaches the concept of translational elongation as a physiological bottleneck during oxidative stress response, where the timely synthesis of protective enzymes is critical for maintaining redox homeostasis and bacterial survival.

This pathophysiology diagram illustrates the eukaryotic translation process, divided into initiation and elongation phases. Panel (a) focuses on translation initiation, showing the assembly of the 43S pre-initiation complex (comprising the 40S subunit, Met-tRNA, and eIFs 1, 1A, 2, and 3) and the eIF4F complex (eIF4E, 4G, 4A, and 4B) at the mRNA 5' cap (m7GpppN). These components converge to form the 48S pre-initiation complex, which scans for the AUG start codon. Regulatory eIF4E-binding proteins (CYFIP1, 4E-T, 4E-HP, 4E-BP) are shown as competitive inhibitors. Panel (b) depicts the elongation cycle: tRNA selection, where an aa-tRNA enters the A site via eEF1-GTP; peptidyl transfer, involving eIF5A1 and the transfer of the polypeptide chain; and translocation, mediated by eEF2-GTP. The diagram highlights the movement of tRNAs through the ribosomal E, P, and A sites. Regulatory phosphorylation of eEF2 by eEF2K is also shown, illustrating translational control mechanisms relevant to cellular proteostasis.
| Polymerase | Products | Inhibited by |
|---|---|---|
| RNA Pol I | 28S, 18S, 5.8S rRNA | - |
| RNA Pol II | mRNA (protein-coding genes), snRNA | α-amanitin (low dose) |
| RNA Pol III | tRNA, 5S rRNA | α-amanitin (high dose) |
| Modification | Details |
|---|---|
| 5' cap | Addition of 7-methylguanosine cap [M(7)GPPP] - protects mRNA, aids ribosome binding |
| 3' poly-A tail | Cleavage at AAUAAA signal, then ~200 adenine residues added - increases mRNA stability |
| RNA splicing | Introns are removed; exons are rejoined by the spliceosome |


| Feature | Prokaryotes | Eukaryotes |
|---|---|---|
| Location | Cytoplasm | Nucleus |
| RNA polymerase | Single (+ sigma factor) | Three (Pol I, II, III) |
| Promoter | -10 and -35 consensus | TATA box (~-25) |
| Coupling with translation | Yes (simultaneous) | No (separated by nuclear envelope) |
| Pre-mRNA processing | None | 5' cap, poly-A tail, splicing |
| Introns | Absent (mostly) | Present |
| mRNA type | Polycistronic | Monocistronic |
| Template strand direction | 3'→5' | 3'→5' |
| RNA synthesis direction | 5'→3' | 5'→3' |

| Feature | Prokaryotes | Eukaryotes |
|---|---|---|
| Ribosome size | 70S (30S + 50S) | 80S (40S + 60S) |
| Initiator tRNA | fMet-tRNA (formyl-methionine) | Met-tRNA_Met (unformylated) |
| mRNA recognition | Shine-Dalgarno sequence | 5' cap scanning + Kozak sequence |
| Initiation factors | IF1, IF2, IF3 | >12 eIFs (eIF1, 1A, 2, 3, 4E, 4G, 4A, 5, 5B...) |
| mRNA type | Polycistronic | Monocistronic |
| Coupling with transcription | Yes | No |
| Location | Cytoplasm | Cytoplasm (free or rER-bound) |
| Elongation factors | EF-Tu, EF-G | eEF1, eEF2 |
| Release factors | RF1, RF2, RF3 | eRF1, eRF3 |
| A, P, E sites | Yes | Yes |
| Antibiotic | Subunit Target | Mechanism |
|---|---|---|
| Aminoglycosides (streptomycin) | 30S | Causes mRNA misreading; blocks initiation; inhibits translocation |
| Tetracyclines | 30S | Block aminoacyl-tRNA binding to A site |
| Macrolides (erythromycin) | 50S | Block peptide exit tunnel; inhibit translocation |
| Lincosamides (clindamycin) | 50S | Block peptide exit tunnel |
| Chloramphenicol | 50S | Inhibits peptidyl transferase |
| Linezolid (oxazolidinone) | 50S | Inhibits 70S initiation complex formation |
| Process | Prokaryote | Eukaryote |
|---|---|---|
| Transcription location | Cytoplasm | Nucleus |
| Translation location | Cytoplasm | Cytoplasm |
| Coupling | Transcription + translation coupled | Separated in space and time |
| mRNA processing | None | 5' cap, poly-A, splicing |
| Ribosome | 70S | 80S |
| Initiator amino acid | fMet | Met |
| mRNA | Polycistronic | Monocistronic |
| Transcription inhibitor | Rifampin | α-amanitin |
Lac operon and tryptophan operon

| Gene | Protein | Function |
|---|---|---|
| lacZ | β-galactosidase | Hydrolyzes lactose → glucose + galactose. Also converts lactose → allolactose (the true inducer) |
| lacY | Permease | Membrane transporter that brings lactose into the cell |
| lacA | Transacetylase | Acetylates β-galactosides (exact role in lactose metabolism unclear) |
| lacI | Lac repressor | Regulatory gene (independently transcribed); produces the repressor protein |


| Condition | Repressor | cAMP-CAP | Transcription |
|---|---|---|---|
| Glucose present, no lactose | Active (on operator) | Absent | Off |
| Lactose present, glucose present | Inactive (inducer bound) | Absent | Very low (basal) |
| Lactose present, no glucose | Inactive | Present | Maximum |
| No lactose, no glucose | Active | Present | Off |
| Tryptophan Level | What Happens | Outcome |
|---|---|---|
| Trp plentiful | Charged trp-tRNA abundant → ribosome translates leader peptide rapidly past Trp codons → ribosome covers region 2 → only terminator hairpin (3:4) forms → premature transcription termination | trp mRNA attenuated; structural genes NOT transcribed |
| Trp scarce | Uncharged trp-tRNA → ribosome stalls at Trp-Trp codons (region 1) → region 2 is exposed → antiterminator hairpin (2:3) forms → prevents terminator hairpin from forming | Transcription continues through structural genes → tryptophan synthesized |
| No translation | Region 1:2 hairpin forms, leading to terminator (like Trp-replete state) | Operon off |

| Condition | Repressor Status | Attenuation | Transcription |
|---|---|---|---|
| Trp absent | Apo-repressor (inactive) | No attenuation (ribosome stalls at Trp codons) | Maximum |
| Trp moderate | Partially active | Partial attenuation | Intermediate |
| Trp abundant | Active repressor-Trp complex on operator | Full attenuation | Off / Minimal |
| Feature | Lac Operon | Trp Operon |
|---|---|---|
| Type | Inducible | Repressible |
| Default state | OFF | ON |
| Effector molecule | Allolactose (inducer) | Tryptophan (co-repressor) |
| Effector action on repressor | Inactivates it (repressor released from operator) | Activates it (repressor binds operator) |
| Structural genes | lacZ, lacY, lacA (3 genes) | trpE, D, C, B, A (5 genes) |
| Products | Lactose-catabolism enzymes | Tryptophan biosynthesis enzymes |
| Control type | Negative + Positive (cAMP-CAP) | Negative only + Attenuation |
| Attenuation | No | Yes (two levels of control) |
| Logic | "Make enzymes only if lactose is present AND glucose is absent" | "Make enzymes unless tryptophan is already abundant" |
| Metabolic direction | Catabolic (breakdown) | Anabolic (biosynthesis) |